These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 25632807)
1. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy. Mooney PD; Wong SH; Johnston AJ; Kurien M; Avgerinos A; Sanders DS Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1278-1284.e1. PubMed ID: 25632807 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease. Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies. Sayed SK; Imam HM; Mahran AM; Refaiy AM Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406 [TBL] [Abstract][Full Text] [Related]
4. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease. Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680 [TBL] [Abstract][Full Text] [Related]
5. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'. Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523 [TBL] [Abstract][Full Text] [Related]
6. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Agardh D Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995 [TBL] [Abstract][Full Text] [Related]
8. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study. Tangermann P; Branchi F; Itzlinger A; Aschenbeck J; Schubert S; Maul J; Liceni T; Schröder A; Heller F; Spitz W; Möhler U; Graefe U; Radke M; Trenkel S; Schmitt M; Loddenkemper C; Preiß JC; Ullrich R; Daum S; Siegmund B; Bojarski C; Schumann M Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1780-1787.e5. PubMed ID: 30267867 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936 [TBL] [Abstract][Full Text] [Related]
11. Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis. Ermarth A; Bryce M; Woodward S; Stoddard G; Book L; Jensen MK Clin Gastroenterol Hepatol; 2017 Mar; 15(3):396-402.e2. PubMed ID: 27847281 [TBL] [Abstract][Full Text] [Related]
12. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. Volta U; Granito A; Parisi C; Fabbri A; Fiorini E; Piscaglia M; Tovoli F; Grasso V; Muratori P; Pappas G; De Giorgio R J Clin Gastroenterol; 2010 Mar; 44(3):186-90. PubMed ID: 20042872 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399 [TBL] [Abstract][Full Text] [Related]
14. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease. Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536 [TBL] [Abstract][Full Text] [Related]
15. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114 [TBL] [Abstract][Full Text] [Related]
16. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease]. Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506 [TBL] [Abstract][Full Text] [Related]
17. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal. Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564 [TBL] [Abstract][Full Text] [Related]